Deubiquitinase

去泛素化酶 (DUB) 是一类蛋白酶,其功能是从与靶底物结合的前蛋白或泛素中裂解泛素 (Ub) 或泛素样蛋白。根据酶促裂解机制,DUB 分为两大类:半胱氨酸蛋白酶和锌金属蛋白酶。这些包括泛素特异性蛋白酶 (USP)、泛素 C 末端水解酶 (UCH)、卵巢肿瘤蛋白酶 (OTU)、Machado-Joseph 病蛋白酶 (MJD)、Jab1/Mov34/Mpr1 (JAMM) 金属蛋白酶和含有 MIU 的新型 DUB 家族 (MINDY) 蛋白酶。

泛素化是一种重要的翻译后修饰,在许多重要的细胞事件中起着关键作用。在此过程中,泛素通过 E1、E2 和 E3 酶的协同作用与底物蛋白结合,然后被 DUB 去除。因此,DUB 是 Ub 系统的重要调节剂,可调节大量细胞过程,包括蛋白质周转、蛋白质分选和运输。DUB 活性改变与多种病理有关,包括癌症。DUB 代表了靶向药物开发的新型候选药物。

Deubiquitinases (DUBs) are a family of proteases whose function is to cleave ubiquitin (Ub) or ubiquitin-like proteins from proproteins or ubiquitin(s) conjugated with target substrate. DUBs are divided into two main classes according to their enzymatic cleavage mechanism: cysteine proteases and zinc metalloproteases. These include ubiquitin-specific proteases (USPs), ubiquitin C-terminal hydrolases (UCHs), ovarian tumor proteases (OTUs), Machado-Joseph disease proteases (MJDs), Jab1/Mov34/Mpr1 (JAMM) metalloproteases, and MIU-containing novel DUB family, (MINDY) proteases.

Ubiquitination is an important post-translational modification that plays a key role in many vital cellular events. In this process, ubiquitin is attached to a substrate protein by the concerted action of an enzyme cascade involving E1, E2 and E3 enzymes and it is removed by DUBs. DUBs are therefore important regulators of the Ub system and regulate a plethora of cellular processes, including protein turnover, protein sorting, and trafficking. Altered DUB activity is associated with a multitude of pathologies including cancer. DUBs represent novel candidates for target-directed drug development.

共 4种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
PROTAC USP7 Degrader-1

PROTAC USP7 Degrader-1 是一种 VHL 招募型 PROTAC 和 USP7 降解剂,具有 USP7 与 VHL E3 泛素连接酶结合活性,可通过招募 VHL E3 连接酶介导 USP7 的泛素化及随后的蛋白水解降解(粉色:USP7 配体 (MS-G32190);蓝色:VHL 配体 (MS-R95960);黑色:连接子)。

Degrader
PROTAC USP7 Degrader-1
PROTAC USP7 Degrader-2

PROTAC USP7 Degrader-2(Compound D16)是一种高效、选择性的 USP7 PROTAC 降解剂,其 DC50 为 1.91 μM(TE-12 细胞),可抑制上消化道(UGI)癌细胞的迁移,同时表现出较弱的抗增殖活性,可用于转移性上消化道癌的研究(粉色:USP7 配体 (MS-J61155);蓝色:Cereblon 配体 (MS-V29738);黑色:连接子)。

3056612-67-7
Degrader
PROTAC USP7 Degrader-2
U7D-1

U7D-1 是一种首创的、有效的和选择性的泛素特异性蛋白酶 7(USP7)PROTAC 降解剂,在 RS4;11 细胞中 DC50 为 33 nM,具有抗癌活性,并可诱导 Jeko-1 细胞凋亡(apoptosis)(粉色:USP7 配体(MS-C74307);蓝色:Cereblon 配体(MS-N78428);黑色:连接子)。

3094177-94-0
Degrader
99.68%
U7D-1
XM-U-14

XM-U-14 是一种选择性 PROTAC USP7 降解剂(在 RS4;11 细胞系中诱导 USP7 降解的 DC50 为 0.74 nM),可上调 p53 和 p21 水平,并显著抑制急性淋巴细胞白血病 (ALL) 细胞生长(IC50:RS4;11 细胞和 Reh 细胞分别为 0.5 nM 和 8.3 nM),诱导细胞凋亡 (Apoptosis) 和周期停滞,同时抑制肿瘤生长(蓝色:VHL 配体 (MS-B32426);黑色:连接子;粉色:USP7 抑制剂)。

3098519-83-3
Degrader
XM-U-14

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础